GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
77.40
+2.10 (2.79%)
Dec 20, 2024, 4:00 PM EST - Market closed
GeneDx Holdings Market Cap
GeneDx Holdings has a market cap or net worth of $2.13 billion as of December 20, 2024. Its market cap has increased by 5,376.39% in one year.
Market Cap
2.13B
Enterprise Value
2.13B
1-Year Change
5,376.39%
Ranking
Category
Stock Price
$77.40
Market Cap Chart
Since November 4, 2020, GeneDx Holdings's market cap has decreased from $17.90B to $2.13B, a decrease of -88.12%. That is a compound annual growth rate of -40.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 2.13B | 2,887.12% |
| Dec 29, 2023 | 71.18M | -30.24% |
| Dec 30, 2022 | 102.04M | -90.52% |
| Dec 31, 2021 | 1.08B | -94.66% |
| Dec 31, 2020 | 20.16B | 12.65% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Iovance Biotherapeutics | 2.24B |
| Tandem Diabetes Care | 2.24B |
| IDEAYA Biosciences | 2.20B |
| Geron | 2.17B |
| CONMED | 2.17B |
| Ligand Pharmaceuticals | 2.15B |
| NeoGenomics | 2.11B |
| Premier | 2.09B |